Revvity
$151.53Change from previous close: +1.66%Absolute change: +$2.47
At a glance
- Revenue growth
- +3.67%
- 2025 vs 2024
- Net income growth
- −10.79%
- 2025 vs 2024
- Net margin
- 8.4%
- 2024: 9.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 730 | 711 | 772 | 699 | 720 | — |
| Cost of revenue | 313 | 323 | 350 | 324 | 328 | — |
| Gross profit | 417 | 388 | 422 | 375 | 393 | — |
| Selling, general and administrative | 280 | 254 | 252 | 242 | 250 | — |
| Research and development | 49.0 | 57.9 | 58.2 | 50.8 | 53.3 | — |
| Operating income | 87.9 | 75.9 | 112 | 81.9 | 89.1 | — |
| EBIT | 58.3 | 74.7 | 115 | 78.5 | 60.3 | — |
| EBITDA | 160 | 180 | 218 | 181 | 163 | — |
| Interest expense | -5.3 | 24.7 | 23.5 | 22.8 | -8.3 | — |
| Pre-tax income | 63.5 | 50.0 | 91.6 | 55.7 | 68.7 | — |
| Income tax | 10.1 | 9.1 | -4.2 | 8.5 | 13.4 | — |
| Net income | 51.8 | 40.7 | 98.4 | 46.7 | 53.9 | — |
| Net income to common shareholders | 51.8 | 40.7 | 98.4 | 46.7 | 53.9 | — |
| Basic EPS | 0.46 | 0.36 | 0.88 | 0.41 | 0.46 | — |
| Diluted EPS | 0.46 | 0.36 | 0.87 | 0.40 | 0.46 | — |
| Average shares (basic) | 112 | 112 | 112 | 114 | 116 | — |
| Average shares (diluted) | 112 | 112 | 113 | 115 | 118 | — |
